Status:
COMPLETED
Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
GlaxoSmithKline
Conditions:
Myocardial Infarction
Death, Sudden, Cardiac
Eligibility:
All Genders
21+ years
Phase:
PHASE3
Brief Summary
Doctors use magnetic resonance imaging (MRI) to obtain detailed pictures of the inside of the body. This study will evaluate a new MRI technique in people who have recently had a heart attack. Researc...
Detailed Description
A new MRI technique to examine the heart was recently developed. In this study, researchers will use this new technique to evaluate the heart in people who have recently had a heart attack to determin...
Eligibility Criteria
Inclusion
- Experienced a heart attack in the 2 to 4 weeks before study entry
- Lives in the greater Boston area or adjacent regions (within a 50-mile radius of Boston)
Exclusion
- Unable to undergo an MRI because of metallic implants (e.g., pacemakers, an implantable cardioverter defibrillator \[AICD\]) at time of study entry
- Active cancer or any other terminal illness with an expected survival rate of less than 6 months after study entry
- Significant kidney dysfunction with a glomerular filtration rate (GFR) of less than 60 mL/min in the 2 weeks before study entry
- Inability to follow study procedures
- Pregnant
- Hemodynamic instability
- Urgent clinical need for a pacemaker or AICD
- Inaccessibility of medical records
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
358 Patients enrolled
Trial Details
Trial ID
NCT00729430
Start Date
August 1 2008
End Date
July 1 2014
Last Update
June 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital, Shapiro Cardiovascular Center
Boston, Massachusetts, United States, 02115